![]() |
|
|
Vol. 53, Issue 4, 708-717, April 1998
Department of Pharmacology, Mayo Medical School, Mayo Clinic, Mayo
Foundation, Rochester, Minnesota 55905
Histamine N-methyltransferase (HNMT) catalyzes a major
pathway in histamine metabolism. Levels of HNMT activity in humans are
regulated by inheritance. We set out to study the molecular basis for
this genetic regulation. Northern blot analysis showed that HNMT is
highly expressed in the kidney, so we determined levels of enzyme
activity and thermal stability in 127 human renal biopsy samples. DNA
was isolated from 12 kidney samples with widely different HNMT
phenotypes, and exons of the HNMT gene were amplified with the polymerase chain reaction. In these 12 samples, we observed a
C314T transition that resulted in a Thr105Ile change in encoded amino
acid, as well as an A939G transition within the 3'-untranslated region.
All remaining renal biopsy samples then were genotyped for these two
variant sequences. Frequencies of the alleles encoding Thr105 and
Ile105 in the 114 samples studied were 0.90 and 0.10, respectively,
whereas frequencies for the nucleotide A939 and G alleles were 0.79 and
0.21, respectively. Kidney samples with the allele encoding Ile105 had
significantly lower levels of HNMT activity and thermal stability than
did those with the allele that encoded Thr105. These observations were
confirmed by transient expression in COS-1 cells of constructs that
contained all four alleles for these two polymorphisms. COS-1 cells
transfected with the Ile105 allele had significantly lower HNMT
activity and immunoreactive HNMT protein than did those transfected
with the Thr105 allele. These observations will make it possible to
test the hypothesis that genetic polymorphisms for HNMT may play a role
in the pathophysiology of human disease.
This article has been cited by other articles:
![]() |
L. Maintz and N. Novak Histamine and histamine intolerance Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1185 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Hon, W. J. Jusko, V. E. Spratlin, and M. W. Jann Altered Methylprednisolone Pharmacodynamics in Healthy Subjects With Histamine N-Methyltransferase C314T Genetic Polymorphism. J. Clin. Pharmacol., April 1, 2006; 46(4): 408 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Wood, O. E. Salavagionne, B. Mukherjee, L. Wang, A. F. Klumpp, B. A. Thomae, B. W. Eckloff, D. J. Schaid, E. D. Wieben, and R. M. Weinshilboum Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics: GENE RESEQUENCING AND FUNCTIONAL GENOMICS STUDIES J. Biol. Chem., March 17, 2006; 281(11): 7364 - 7373. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. E. Salavaggione, C. Yang, L. B. Kidd, B. A. Thomae, V. S. Pankratz, L. A. Trepanier, and R. M. Weinshilboum Cat Red Blood Cell Thiopurine S-Methyltransferase: Companion Animal Pharmacogenetics J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 617 - 626. [Abstract] [Full Text] [PDF] |
||||